Jim Beitel

Jim Beitel serves as the Chief Business Officer at Cidara Therapeutics since August 2024, bringing extensive experience in corporate development and strategy across various biopharmaceutical companies. Prior roles include Senior Vice President of Corporate Development at Fate Therapeutics Inc, where Jim contributed to the advancement of innovative cell therapies, and Vice President at Avanir Pharmaceuticals, overseeing multiple corporate functions. Jim's career features significant achievements, including a $210M discovery deal at Zacharon Pharmaceuticals and pivotal transactions at La Jolla Pharmaceutical Company. Educational credentials include an M.B.A. from Harvard Business School and a B.S. in Engineering from The University of Kansas.